A detailed history of Xtx Topco LTD transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 13,154 shares of FULC stock, worth $93,261. This represents 0.02% of its overall portfolio holdings.

Number of Shares
13,154
Holding current value
$93,261
% of portfolio
0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$6.7 - $12.0 $88,131 - $157,848
13,154 New
13,154 $124,000
Q3 2023

Nov 13, 2023

SELL
$3.25 - $6.08 $143,806 - $269,027
-44,248 Reduced 53.2%
38,918 $172,000
Q2 2023

Aug 14, 2023

SELL
$2.26 - $3.8 $91,760 - $154,287
-40,602 Reduced 32.8%
83,166 $274,000
Q1 2023

May 12, 2023

BUY
$2.83 - $13.99 $251,547 - $1.24 Million
88,886 Added 254.82%
123,768 $352,000
Q4 2022

Feb 14, 2023

BUY
$5.35 - $7.28 $186,618 - $253,940
34,882 New
34,882 $253,000
Q2 2022

Aug 15, 2022

BUY
$4.2 - $24.0 $116,755 - $667,176
27,799 New
27,799 $136,000

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $369M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.